Molecular targets to treat muscular dystrophies.

Article Details

Citation
Copy to clipboard

Kinter J, Sinnreich M

Molecular targets to treat muscular dystrophies.

Swiss Med Wkly. 2014 Feb 19;144:w13916. doi: 10.4414/smw.2014.13916.

PubMed ID
24554202 [ View in PubMed
]
Abstract

Muscular dystrophies are classically subdivided according to their clinical phenotype, and were historically defined as progressive myopathies in which muscle biopsies demonstrate muscle fibre necrosis and regeneration, as well as replacement of muscle fibres by adipose and connective tissue. In recent years, great progress has been made in identifying the genetic basis of many myopathies, thereby presenting opportunities to develop therapeutic strategies that act on specific molecular pathomechanisms. The different therapeutic strategies and their molecular targets will be reviewed.

DrugBank Data that Cites this Article

Drugs
Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
GolodirsenDystrophinProteinHumans
Yes
Inducer
Details